Filtered by Tag: Ginkgo Bioworks

Pomerantz Appointed Lead Counsel in Ginkgo Bioworks Securities Litigation

On March 25, 2022, U.S. District Judge Yvonne Gonzalez Rogers of the Northern District of California (Oakland Division) appointed Pomerantz LLP as Lead Counsel on behalf of Sharon Bernstein, the Lead Plaintiff, and the class, in Stuart v. Ginkgo Bioworks Holdings, Inc., 4:21-cv-08943-YGR (N.D.Ca.). This securities action alleges that Ginkgo Bioworks Holdings, Inc. misrepresented and misclassified its sources of revenue in order to conceal its dependence on undisclosed related parties. Ginkgo is a biotech company that operates a platform for cell programming, designed to enable biological production of products as diverse as novel…

Read More